Literature DB >> 17531610

Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action.

María Elena Ortiz1, Horacio B Croxatto.   

Abstract

All intrauterine devices (IUDs) that have been tested experimentally or clinically induce a local inflammatory reaction of the endometrium whose cellular and humoral components are expressed in the tissue and the fluid filling the uterine cavity. Depending on the reproductive strategy of the species considered and the anatomical features and physiologic mechanisms that characterize their reproductive system, the secondary consequences of this foreign body reaction can be very localized within the uterus, as in the rabbit, or widespread throughout the entire genital tract as in women or even systemic as in some farm animals. Levonorgestrel released from an IUD causes some systemic effects, but local effects such as glandular atrophy and stromal decidualization, in addition to the foreign body reaction, are dominant. Copper ions released from an IUD enhance the inflammatory response and reach concentrations in the luminal fluids of the genital tract that are toxic for spermatozoa. In the human, the entire genital tract appears affected due to luminal transmission of the noxa that accumulates in the uterine lumen. This affects the function and viability of gametes, decreasing the rate of fertilization and lowering the chances of survival of any embryo that may be formed, before it reaches the uterus. The bulk of the data indicate that if any embryos are formed in the chronic presence of an IUD, it happens at a much lower rate than in non-IUD users. The common belief that the usual mechanism of action of IUDs in women is destruction of embryos in the uterus is not supported by empirical evidence.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17531610     DOI: 10.1016/j.contraception.2007.01.020

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  42 in total

1.  Improving information on intrauterine contraception: providing advice in primary care.

Authors:  Hannat Akintomide
Journal:  Br J Gen Pract       Date:  2019-02       Impact factor: 5.386

2.  Pregnancy after solid organ transplantation: a guide for obstetric management.

Authors:  Neha A Deshpande; Lisa A Coscia; Veronica Gomez-Lobo; Michael J Moritz; Vincent T Armenti
Journal:  Rev Obstet Gynecol       Date:  2013

3.  The effect of intrauterine devices on acquisition and clearance of human papillomavirus.

Authors:  Sarah H Averbach; Yifei Ma; Karen Smith-McCune; Stephen Shiboski; Anna B Moscicki
Journal:  Am J Obstet Gynecol       Date:  2016-12-14       Impact factor: 8.661

Review 4.  Contraceptive Considerations for Women with Gastrointestinal Disorders.

Authors:  Aparna Sridhar; Carrie A Cwiak; Andrew M Kaunitz; Rebecca H Allen
Journal:  Dig Dis Sci       Date:  2016-11-24       Impact factor: 3.199

Review 5.  Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).

Authors:  Caitlin Parks; Jeffrey F Peipert
Journal:  Am J Obstet Gynecol       Date:  2016-02-12       Impact factor: 8.661

6.  Recent intrauterine device use and the risk of precancerous cervical lesions and cervical cancer.

Authors:  Sarah Averbach; Michael J Silverberg; Wendy Leyden; Karen Smith-McCune; Tina Raine-Bennett; George F Sawaya
Journal:  Contraception       Date:  2018-04-17       Impact factor: 3.375

Review 7.  Contraception for cancer survivors.

Authors:  Eleanor Bimla Schwarz; Rachel Hess; James Trussell
Journal:  J Gen Intern Med       Date:  2009-11       Impact factor: 5.128

8.  Impact of long-term contraceptive promotion on incident pregnancy: a randomized controlled trial among HIV-positive couples in Lusaka, Zambia.

Authors:  Kristin M Wall; Bellington Vwalika; Lisa Haddad; Naw H Khu; Cheswa Vwalika; William Kilembe; Elwyn Chomba; Rob Stephenson; David Kleinbaum; Azhar Nizam; Ilene Brill; Amanda Tichacek; Susan Allen
Journal:  J Acquir Immune Defic Syndr       Date:  2013-05-01       Impact factor: 3.731

9.  Ovarian cancer risk factors by tumor dominance, a surrogate for cell of origin.

Authors:  Joanne Kotsopoulos; Kathryn L Terry; Elizabeth M Poole; Bernard Rosner; Megan A Murphy; Jonathan L Hecht; Christopher P Crum; Stacey A Missmer; Daniel W Cramer; Shelley S Tworoger
Journal:  Int J Cancer       Date:  2013-03-13       Impact factor: 7.396

10.  Evaluation of pigtail macaques as a model for the effects of copper intrauterine devices on HIV infection.

Authors:  Robyn M Engel; Monica Morris; Tara Henning; Jana M Ritter; Tara L Jones; Sharon Dietz; Jessica Ayers; Sundaram A Vishwanathan; Leecresia Jenkins; Sherif Zaki; Dirk Wildemeersch; David Garber; Nathaniel Powell; R Michael Hendry; Janet McNicholl; Ellen N Kersh
Journal:  J Med Primatol       Date:  2013-12-27       Impact factor: 0.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.